Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Doi

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 19, 2013
[Chemotherapy for GI and pancreatic NETs]Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 20, 2008
[GIST]Toshihiko Doi
The Lancet. Oncology|April 13, 2016
Pazopanib for both GIST and soft-tissue sarcomaToshirou Nishida, Toshihiko Doi
The Lancet. Oncology|December 3, 2014
Improving prognosis after surgery for gastric cancerToshirou Nishida, Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2016
[Molecular Subtypes of Gastric Cancer]Ken Hatogai, Toshihiko Doi
The Lancet. Oncology|June 9, 2020
A new approach to refractory gastrointestinal stromal tumours with diverse acquired mutationsToshirou Nishida, Toshihiko Doi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Clinical research of targeting therapy for cancer stem cells]Kohei Shitara, Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Novel molecular-targeted agents for GIST(Regorafenib etc.)]Yoichi Naito, Toshihiko Doi
The Lancet. Oncology|October 22, 2013
Rechallenge of drugs in the era of targeted therapyToshirou Nishida, Toshihiko Doi
Current Oncology Reports|April 1, 2017
Immunotherapy for Esophageal Squamous Cell CarcinomaTakashi Kojima, Toshihiko Doi
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 19, 2013
[Chemotherapy for GI and pancreatic NETs]Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 20, 2008
[GIST]Toshihiko Doi
The Lancet. Oncology|April 13, 2016
Pazopanib for both GIST and soft-tissue sarcomaToshirou Nishida, Toshihiko Doi
The Lancet. Oncology|December 3, 2014
Improving prognosis after surgery for gastric cancerToshirou Nishida, Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2016
[Molecular Subtypes of Gastric Cancer]Ken Hatogai, Toshihiko Doi
The Lancet. Oncology|June 9, 2020
A new approach to refractory gastrointestinal stromal tumours with diverse acquired mutationsToshirou Nishida, Toshihiko Doi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 20, 2015
[Clinical research of targeting therapy for cancer stem cells]Kohei Shitara, Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Novel molecular-targeted agents for GIST(Regorafenib etc.)]Yoichi Naito, Toshihiko Doi
The Lancet. Oncology|October 22, 2013
Rechallenge of drugs in the era of targeted therapyToshirou Nishida, Toshihiko Doi
Current Oncology Reports|April 1, 2017
Immunotherapy for Esophageal Squamous Cell CarcinomaTakashi Kojima, Toshihiko Doi
Pageof 26